Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Annual Review of Genomics and Human Genetics|July 2, 2010
Profiling the cancer genomePrue A Cowin, Michael Anglesio, Dariush Etemadmoghadam, et al.
The Journal of Pathology|March 27, 2015
Efficient molecular subtype classification of high-grade serous ovarian cancerHuei San Leong, Laura Galletta, Dariush Etemadmoghadam, et al.
Gynecologic Oncology|September 14, 2018
19q12 amplified and non-amplified subsets of high grade serous ovarian cancer with overexpression of cyclin E1 differ in their molecular drivers and clinical outcomesDiar Aziz, Dariush Etemadmoghadam, C Elizabeth Caldon, et al.
Immunology and Cell Biology|January 13, 2006
Activators of the energy sensing kinase AMPK inhibit random cell movement and chemotaxis in U937 cellsJohn Kanellis, Rangi K Kandane, Dariush Etemadmoghadam, et al.
Plos One|November 25, 2010
Amplicon-dependent CCNE1 expression is critical for clonogenic survival after cisplatin treatment and is correlated with 20q11 gain in ovarian cancerDariush Etemadmoghadam, Joshy George, Prue A Cowin, et al.
American Journal of Physiology. Renal Physiology|October 23, 2003
Stanniocalcin-1, an inhibitor of macrophage chemotaxis and chemokinesisJohn Kanellis, Roger Bick, Gabriela Garcia, et al.
BMC Cancer|September 4, 2007
High resolution melting for mutation scanning of TP53 exons 5-8Michael Krypuy, Ahmed Ashour Ahmed, Dariush Etemadmoghadam, et al.
Cancer Research|December 25, 2013
Cyclin E1 deregulation occurs early in secretory cell transformation to promote formation of fallopian tube-derived high-grade serous ovarian cancersAlison M Karst, Paul M Jones, Natalie Vena, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 2, 2013
Nonequivalent gene expression and copy number alterations in high-grade serous ovarian cancers with BRCA1 and BRCA2 mutationsJoshy George, Kathryn Alsop, Dariush Etemadmoghadam, et al.
The Journal of Pathology|March 16, 2010
Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovaryAhmed Ashour Ahmed, Dariush Etemadmoghadam, Jillian Temple, et al.
Pageof 4